A new preclinical study by Mass Eye and Ear investigators showed that a novel mRNA-based therapy may be able to prevent blindness and scarring from proliferative vitreoretinopathy (PVR) following a ...
The global glioblastoma multiforme treatment market size was valued at USD 2.78 billion in 2024 and is expected to reach around USD 5.68 billion by 2033, registering a CAGR of 8.23% from 2024 to 2033.
Ablation, a procedure to treat abnormal electrical short circuits caused by a heart attack and is usually reserved for patients who do not improve with medication, may be a better ...